Lymphadenectomy—D1, D2, and D3
Fig. 13.1 Lymph node stations as described by the JRSGC Table 13.1 Lymph node stations and their anatomical borders [5] Station Description Anatomical border 1 Right cardiac Perigastric nodes on…
Fig. 13.1 Lymph node stations as described by the JRSGC Table 13.1 Lymph node stations and their anatomical borders [5] Station Description Anatomical border 1 Right cardiac Perigastric nodes on…
Fig. 2.1 Gastric cancer (GC) histotypes according to Laurèn classification. a. Intestinal-type GC: glandular cancer structures of different size infiltrating the gastric wall (H&E, original magnification 40 ×). b Diffuse-type GC:…
Fig. 5.1 Specificity of 89Zr-trastuzumab for HER2-positive tumors. Coronal 89Zr-trastuzumab, 18F-FDG, and 18F-FLT PET images of athymic nude mice bearing subcutaneous HER2-positive NCI-N87 ( left) and HER2-negative MKN-74 ( right)…
Clinical phase Compound Type of compound Target Study details +/- preliminary findings I MGAH22 mAb HER2 Dose escalation study of MGAH22 in patients with refractory HER2-positive breast cancer and patients…